Daniela Lener

794 total citations
17 papers, 213 citations indexed

About

Daniela Lener is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Daniela Lener has authored 17 papers receiving a total of 213 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Cardiology and Cardiovascular Medicine, 5 papers in Pulmonary and Respiratory Medicine and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Daniela Lener's work include Cerebrovascular and Carotid Artery Diseases (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Daniela Lener is often cited by papers focused on Cerebrovascular and Carotid Artery Diseases (3 papers), Atherosclerosis and Cardiovascular Diseases (3 papers) and Protease and Inhibitor Mechanisms (3 papers). Daniela Lener collaborates with scholars based in Austria, Italy and Germany. Daniela Lener's co-authors include Markus Theurl, Rudolf Kirchmair, Karin Albrecht-Schgoer, Wilfried Schgoer, Can Gollmann‐Tepeköylü, Johannes Holfeld, Michael Grimm, Peter Marschang, Elke Kirchmair and Daniela Lobenwein and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and The FASEB Journal.

In The Last Decade

Daniela Lener

17 papers receiving 209 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniela Lener Austria 8 65 60 34 30 29 17 213
Liyi Huang China 11 80 1.2× 93 1.6× 11 0.3× 12 0.4× 15 0.5× 19 339
Masaya Matsumoto Japan 10 86 1.3× 46 0.8× 32 0.9× 21 0.7× 100 3.4× 18 332
Jiewen Jin China 11 100 1.5× 92 1.5× 35 1.0× 18 0.6× 47 1.6× 31 321
Jiwu Chen China 11 179 2.8× 55 0.9× 8 0.2× 34 1.1× 43 1.5× 21 364
Jelena Rakočević Serbia 8 71 1.1× 55 0.9× 50 1.5× 6 0.2× 21 0.7× 32 257
Daniela Lobenwein Austria 9 51 0.8× 66 1.1× 55 1.6× 79 2.6× 37 1.3× 17 283
Ming‐Rui Du China 11 98 1.5× 133 2.2× 10 0.3× 12 0.4× 23 0.8× 22 353
Jijie Hu China 11 144 2.2× 69 1.1× 12 0.4× 6 0.2× 21 0.7× 29 337
Baochang Qi China 9 53 0.8× 108 1.8× 18 0.5× 49 1.6× 10 0.3× 25 290

Countries citing papers authored by Daniela Lener

Since Specialization
Citations

This map shows the geographic impact of Daniela Lener's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Lener with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Lener more than expected).

Fields of papers citing papers by Daniela Lener

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Lener. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Lener. The network helps show where Daniela Lener may publish in the future.

Co-authorship network of co-authors of Daniela Lener

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Lener. A scholar is included among the top collaborators of Daniela Lener based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Lener. Daniela Lener is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sommer, P, Michael Schreinlechner, Daniela Lener, et al.. (2024). Hepatocyte growth factor as indicator for subclinical atherosclerosis. VASA. 53(2). 120–128. 3 indexed citations
2.
Schreinlechner, Michael, P Sommer, Daniela Lener, et al.. (2023). Inverse Correlation of Cholesterol Efflux Capacity with Peripheral Plaque Volume Measured by 3D Ultrasound. Biomedicines. 11(7). 1918–1918. 4 indexed citations
3.
Sommer, P, Michael Schreinlechner, Daniela Lener, et al.. (2023). Increasing Soluble P-Selectin Levels Predict Higher Peripheral Atherosclerotic Plaque Progression. Journal of Clinical Medicine. 12(20). 6430–6430. 7 indexed citations
4.
Schuetz, Thomas, Marc‐Michael Zaruba, Daniela Lener, et al.. (2023). Correlation of 99mTc-DPD bone scintigraphy with histological amyloid load in patients with ATTR cardiac amyloidosis. Amyloid. 31(1). 22–31. 6 indexed citations
5.
Lener, Daniela, Elke Kirchmair, Axel Bauer, et al.. (2023). The angiogenic neuropeptide catestatin exerts beneficial effects on human coronary vascular cells and cardiomyocytes. Peptides. 168. 171077–171077. 4 indexed citations
6.
Sommer, P, Michael Schreinlechner, Daniela Lener, et al.. (2021). High baseline fetuin-A levels are associated with lower atherosclerotic plaque progression as measured by 3D ultrasound. SHILAP Revista de lepidopterología. 45. 10–17. 6 indexed citations
7.
Schreinlechner, Michael, Sebastian J. Reinstadler, P Sommer, et al.. (2020). Early onset of menopause is associated with increased peripheral atherosclerotic plaque volume and progression. Atherosclerosis. 297. 25–31. 12 indexed citations
8.
Sahanic, Sabina, Thomas Sonnweber, Alex Pizzini, et al.. (2020). Late Breaking Abstract - Persisting pulmonary impairment following severe SARS-CoV-2 infection, preliminary results from the CovILD study. 4143–4143. 4 indexed citations
9.
Schreinlechner, Michael, Daniela Lener, Axel Bauer, et al.. (2020). NGAL Correlates with Femoral and Carotid Plaque Volume Assessed by Sonographic 3D Plaque Volumetry. Journal of Clinical Medicine. 9(9). 2811–2811. 7 indexed citations
10.
Gollmann‐Tepeköylü, Can, Daniela Lobenwein, Markus Theurl, et al.. (2018). Shock Wave Therapy Improves Cardiac Function in a Model of Chronic Ischemic Heart Failure: Evidence for a Mechanism Involving VEGF Signaling and the Extracellular Matrix. Journal of the American Heart Association. 7(20). e010025–e010025. 30 indexed citations
11.
Theurl, Markus, Daniela Lener, Karin Albrecht-Schgoer, et al.. (2018). Gene therapy with the angiogenic neuropeptide secretoneurin ameliorates experimental diabetic neuropathy. The FASEB Journal. 32(9). 4815–4823. 8 indexed citations
12.
Albrecht-Schgoer, Karin, Jan Barthelmes, Wilfried Schgoer, et al.. (2017). Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model. Journal of Controlled Release. 250. 1–8. 24 indexed citations
13.
Graber, Michael, Jakob Hirsch, Elke Kirchmair, et al.. (2017). 39Toll-like receptor 3 mediates the onset of calcific aortic valve disease. European Heart Journal. 38(suppl_1). 1 indexed citations
14.
Holfeld, Johannes, Can Gollmann‐Tepeköylü, Stefan Blunder, et al.. (2014). Low Energy Shock Wave Therapy Induces Angiogenesis in Acute Hind-Limb Ischemia via VEGF Receptor 2 Phosphorylation. PLoS ONE. 9(8). e103982–e103982. 46 indexed citations
15.
Theurl, Markus, Wilfried Schgoer, Karin Albrecht-Schgoer, et al.. (2014). Secretoneurin gene therapy improves hind limb and cardiac ischaemia in Apo E−/− mice without influencing systemic atherosclerosis. Cardiovascular Research. 105(1). 96–106. 14 indexed citations
16.
Schgoer, Wilfried, Markus Theurl, Karin Albrecht-Schgoer, et al.. (2013). Secretoneurin Gene Therapy Improves Blood Flow in an Ischemia Model in Type 1 Diabetic Mice by Enhancing Therapeutic Neovascularization. PLoS ONE. 8(9). e74029–e74029. 17 indexed citations
17.
Albrecht-Schgoer, Karin, Wilfried Schgoer, Markus Theurl, et al.. (2013). Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF. Angiogenesis. 17(1). 27–36. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Liyi Huang Breakdown of academic impact, for papers by Masaya Matsumoto Breakdown of academic impact, for papers by Jiewen Jin Breakdown of academic impact, for papers by Jiwu Chen Breakdown of academic impact, for papers by Jelena Rakočević Breakdown of academic impact, for papers by Daniela Lobenwein Breakdown of academic impact, for papers by Ming‐Rui Du Breakdown of academic impact, for papers by Jijie Hu Breakdown of academic impact, for papers by Baochang Qi
Rankless by CCL
2026